3 stellar ASX growth shares to buy

ResMed Inc. (ASX:RMD) and these ASX growth shares could be top options for growth investors right now. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market is home to a large number of companies that have been growing at a strong rate in recent years.

Three that have been tipped to continue this positive form are listed below. Here's why they could be top options for growth investors:

Surge in ASX share price represented by happy woman pointing to her big smile

Image source: Getty Images

Appen Ltd (ASX: APX)

Appen is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). It has team of over a million contractors spread out across the world preparing or creating the data for the machine learning models of some of the world's largest companies and government agencies. Due to favourable industry tailwinds, analysts at Morgan Stanley believe it has strong long term growth potential. They recently put an overweight rating and $40.00 price target on its shares.

NEXTDC Ltd (ASX: NXT)

NEXTDC is one of the region's leading data centre operators. It has been delivering strong revenue and operating earnings growth in recent years thanks to increasing demand for capacity in its centres. The catalyst for this has been the structural shift to the cloud, which has accelerated during the pandemic. One broker that is very positive on its future is Goldman Sachs. It recently reiterated its buy rating and $13.20 price target on its shares. The broker even suggested the NEXTDC share price could go to $20.00 based on high but not unrealistic assumptions.

ResMed Inc. (ASX: RMD)

ResMed is a medical device company which has been growing at a consistently strong rate over the last decade. This has been underpinned by its industry-leading sleep treatment products and its growing market opportunity. Pleasingly for shareholders, its market is still growing strongly. Management believes there are upwards of a billion people suffering from sleep apnoea globally. As more and more become aware of the disorder and seek treatment, the company is in a strong position to benefit. Analysts at Morgans are positive on its outlook. They have an add rating and $30.99 price target on its shares.

James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Happy man at an ATM.
Growth Shares

Forget CBA: 3 ASX shares with better growth prospects

These shares might be better options for growth investors than Australia's largest bank.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These ASX shares have excellent growth outlooks.

Read more »

Rocket powering up and symbolising a rising share price.
Growth Shares

SpaceX climbs nearly 20% after its IPO. Here's why that is good news for these ASX shares

SpaceX shares are up significantly since their IPO. Here's why that is great news for two ASX-listed stocks.

Read more »

Business people discussing project on digital tablet.
Growth Shares

Where to invest $20,000 in ASX 200 shares in June

Wondering where to invest? Here are three shares that analysts rate as buys.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Growth Shares

Brokers rate these 6 ASX 200 shares a strong buy, and tip upsides of up to 227%

It looks like these ASX 200 shares could drag the index higher over the next 12 months.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Growth Shares

3 incredible ASX growth shares tipped to rise 20% to 70%

Brokers are tipping these shares to rise strongly from current levels.

Read more »

a man sits on a ridge high above a large city full of high rise buildings as though he is thinking, contemplating the vista below.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These two investments look like excellent long-term buys today!

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Growth Shares

2 incredible ASX 200 shares to buy and hold for 10 years

These shares could help you build wealth over the long term.

Read more »